Skip to main content

Strategic Internet IntelligenceJul 20, 2026

Intelligence Directory

Sign In Register

Disciplined intelligence layer in internet infrastructure, governance, and digital capital markets.

Governance

RIR Watchdog
Case File
Number Resource Society
ICANN
IETF
History of Internet
Network Operator Group (NOGs)
RIR Directory

Market

People
Trends
Companies

Membership

Leadership Alliance
Strategic Circle

Framework

Clarity over amplification

Evidence over sentiment

Systems over noise

About BTW Contact Us Join Our Team Privacy Policy Terms of Service

Chemie Grünenthal GmbH Network Infrastructure Profile - BTW Media

Home
Internet Infrastructure Intelligence Directory
Chemie Grünenthal GmbH

Intelligence Directory

Chemie Grünenthal GmbH

Chemie Grünenthal GmbH is connected with ASN/IP network resources in United States.

Identity: Chemie Grünenthal GmbH, Institution

Jump within this record

SectionWhat to know first
SectionBasic information
SectionLocations
SectionOther network resources
SectionPeople and contacts
SectionRegistry and related records
SectionRelated research

Directory Home Organizations Resources Services Locations People

Organization

Chemie Grünenthal GmbH

Chemie Grünenthal GmbH is connected with ASN/IP network resources in United States.

Institution

What to know first

IdentityChemie Grünenthal GmbH, InstitutionHigh confidence

Basic information

Display nameChemie Grünenthal GmbHHigh confidence
Legal typeInstitutionHigh confidence
Directory categoryInstitutionHigh confidence
Last updatedJul 18, 2026High confidence

Locations

Geography scopeUnited States / Europe & Middle EastHigh confidence
Other infrastructure servicesUnited States / Europe & Middle EastMedium confidence

Other network resources

Service platformChemie Grünenthal GmbH United States Other infrastructure services · United States / Europe & Middle EastUnrated

People and contacts

ContactsPolicyMedium confidence
Available contact typesPolicyMedium confidence

Registry and related records

Coverage contextThalidomide made teratogenic-risk evidence and drug approval a pharmaceutical-accountability test, Thalidomide became a pharmaceutical-accountability test because a medicine promoted as a sedative and remedy for pregnancy-related discomfort crossed national markets without an evidence system capable of protecting embryonic development; because clinicians' recognition of an unusual malformation pattern had to overcome fragmented reporting, commercial distribution and regulatory differences; and because withdrawal, litigation, compensation and later tightly controlled uses answered different questions rather than producing one global verdict.Medium confidence

Related research

Primary articleThalidomide made teratogenic-risk evidence and drug approval a pharmaceutical-accountability testHigh confidence

Continue browsing

Organizations Resources People

Government body